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Sensory gating refers to the central nervous system's ability to filter sensory inputs, and can be
measured by comparing the suppression of event-related brain potential (ERP) amplitudes in a
paired auditory stimulus procedure. Poor gating scores in schizophrenia may be caused by
abnormal responses to the first (S1), the second (S2) or both of the paired stimuli. However,
since S1 and S2 responses may index separate psychological phenomenon, corresponding to
the ability to “gate in” and “gate out” sensory stimuli respectively, the precise mechanism
affected in schizophrenia remains unclear. To examine the extent to which saliency processing
abnormalities may contribute to S1 response deficits, standard and rare (15% probability)
paired stimuli were presented to 21 participants with schizophrenia and 22 healthy controls.
P50 and N100 ERP amplitude as well as low, beta and gamma frequency power were measured
to examine the time course and relative contributions of oscillatory activity affecting auditory
processing in schizophrenia. In this study, schizophrenia patients exhibited less evoked beta 1
power (12–20 Hz) in response to salient stimuli at S1, and lower N100 amplitude in response to
all S1 stimuli. No group differences were found in the low, beta 2 (20–30 Hz), or gamma
frequency ranges. These findings suggest aberrant sensory processing during stages of stimulus
evaluation and saliency detection in schizophrenia.









“Sensory gating” refers to the central nervous system's
ability to filter sensory inputs. Onemethod of assessing sensory
gating involves measuring mid-latency auditory evoked
responses (MLAERs) to paired auditory stimuli. During this
procedure, suppression of P50 amplitude to the second
stimulus (S2) is ostensibly caused by recurrent inhibitory
mechanisms activated by the first (S1) stimulus (Freedman
et al.,1987). P50magnitude of response ismost often expressed
as a ratio, with amplitude of the response to the second click
divided by the amplitude of the response to the first click.
Similarly, the N100 also exhibits a pattern of suppression to
repeated stimuli. Schizophrenia subjects generally exhibit less
sensory gating than healthy subjects for both of these MLAERs
Schizophrenia Research 113 (2009) 332–338
⁎ Corresponding author. Tel.: +1 604 822 4650; fax: +1 604 822 6923.
E-mail addresses: cbrenner@psych.ubc.ca (C.A. Brenner),
pdkieffaber@wm.edu (P.D. Kieffaber), clementz@uga.edu (B.A. Clementz),
Jason.Johannesen@yale.edu (J.K. Johannesen), ashekhar@iupui.edu
(A. Shekhar), bodonnel@indiana.edu (B.F. O'Donnell), whetrick@indiana.edu
(W.P. Hetrick).
0920-9964/$ – see front matter © 2009 Elsevier B.V. All rights reserved.
doi:10.1016/j.schres.2009.06.012
Contents lists available at ScienceDirect
Schizophrenia Research
j ourna l homepage: www.e lsev ie r.com/ locate /schres
(Boutros et al., 2004; Clementz et al., 2003; Clementz, 1998;
Clementz et al., 1997a; Patterson et al., 2008). Such findings are
hypothesized to reflect neuronal gating deficits in schizophre-
nia that may cause sensory inundation and ‘flooding’ (Bunney
et al.,1999);howevermuch remains to beunderstoodabout the
neuronal and cognitive mechanisms that influence sensory
gating.
To this end, one important line of research aims to
determine the factors that contribute to sensory gating scores
among both healthy and pathological groups. One possibility
is that gating is poor because S2 response amplitude is not
suppressed compared to an otherwise normal S1 response. In
this case, poor sensory gating indicates a failure of inhibitory
neural mechanisms responsible for “gating out” redundant
and irrelevant sensory stimuli (Clementz et al., 1997b;
Freedman et al., 1987). A second pattern that leads to poor
gating scores occurs when S1 response amplitude is abnor-
mally small in the presence of an otherwise normal S2
response (Blumenfeld and Clementz, 2001; Clementz et al.,
2003; Johannesen et al., 2005). One interpretation of this
pattern is that poor gating is due to a failure of the nervous
system to register and/or attend to the S1 stimulus. This
conceptualization is consistent with the claim of Boutros and
Belger (1999), that ERPs elicited in the paired stimuli
procedure reflect the abilities of the nervous system to both
(i) filter out extraneous information (as measured by ERP
amplitude suppression at S2) and (ii) ‘gate in’ novel, or
salient, information (as measured by ERP amplitude to S1).
Interestingly, there is evidence for both “gating in” and
“gating out” deficits in schizophrenia during the typical
paired stimuli paradigm. However, whether MLAERs asso-
ciated with “gating in” or “gating out” are differentially
affected by manipulations of attention and expectancy
(which are known to affect overall sensory gating scores)
remains an important empirical question (Clementz et al.,
2002; Cullum et al., 1993; Erwin et al., 1998; Guterman et al.,
1992; Kogoj et al., 2005; Thoma et al., 2003; Woldorff et al.,
1993).
Most sensory gating studies have relied on time domain
ERP amplitude measurements. However, recent studies
employing spectral frequency analyses have provided addi-
tional information about auditory sensory processing in
schizophrenia. For instance, poor gating may, in part, reflect
attenuated neural activation in response to S1 (i.e., “gating in”
deficits) in the 1–20 Hz bandwidth (Blumenfeld and Clem-
entz, 2001; Johannesen et al., 2005). Consistent with data
demonstrating that beta activity reflects encoding, salience
detection and consolidation of sensory information, Hong
et al. (2008) found that beta activity in response to S1
predicted stronger gating and P50 suppression to S2 (Bibbig
et al., 2001; Kisley and Cromwell, 2006; Hong et al., 2008).
Neural activity in the gamma frequency range, previously
associated with immediate sensory registration, contributes
to the morphology of the P50 ERP component (Kopell et al.,
1999; Clementz and Blumenfeld, 2001), but the findings
regarding the contribution of gamma activity to auditory
sensory gating deficits in schizophrenia are unclear. Some
studies have failed to find differences in the gamma band
response between healthy and schizophrenia participants
(Clementz and Blumenfeld, 2001; Clementz et al., 1997a),
whereas others have reported decreased gamma and low
frequency responses to S1 in schizophrenia (Johannesen et al.,
2005) as well as a selective reduction in gamma band
suppression in association with higher ratings of subjective
perceptual disturbance (Johannesen et al., 2008). Therefore, it
is important to further evaluate the frequency composition of
EEG activity elicited by manipulations of the paired stimuli
paradigm. Given the emerging data on the functional
significance of oscillatory activity within specific frequency
ranges (Deiber et al., 2007; Kisley and Cromwell, 2006;
Klimesch, 1999; Krishnan et al., 2005; Palva and Palva, 2007;
Pantev et al., 1991; Pesonen et al., 2007; Schack et al., 2005;
Tallon-Baudry, 2003; Trautner et al., 2006; Whittington et al.,
1997), it is likely that assessing activity in these bands will
provide information about the underlying neurophysiological
and cognitive deficits in those with schizophrenia.
Therefore, the primary aims of the present study were to
characterize the frequency composition of the MLAER
electrophysiological response and explicate the nature of
the differences between schizophrenia and healthy subjects
with respect to the frequency composition of responses at S1
and S2 in the paired stimuli paradigm. First, we examined the
effects of stimulus salience on MLAER responses, and
predicted that (i) salient stimuli (infrequent paired clicks of
a deviant pitch) would augment evoked response amplitudes
across all participants, but (ii) schizophrenia subjects would
have less augmentation than controls to rare stimuli. Second,
we sought to determine whether differences in schizophrenia
are better explained by difficulty “gating in” salient sensory
information at S1 or to difficulty “gating out” redundant
sensory information at S2, and predicted that (iii) schizo-
phrenia subjects would have “gating in” deficits as indicated
by reduced S1 amplitudes to both frequent and rare stimuli.
Third, we examined which frequency band best accounted for
S1 and gating deficits in schizophrenia, and predicted, based
on previously reported associations between beta frequency
activity and salient stimulus processing, that (iv) low beta
(12–20 Hz) frequency information would best account for
stimulus-driven salience effects. These finding provide amore
comprehensive characterization of the neurophysiological
and cognitive processes that best account for poor auditory
gating in schizophrenia.
2. Materials and methods
2.1. Participants
The participants were 21 individuals (3 females, mean
age=36, SD=13) meeting criteria for schizophrenia
(N=17) or schizoaffective disorder (N=4) based on the
Structured Clinical Interview for DSM-IV (1994) and 22
healthy persons (6 females, mean age=38, SD=11) free
from any Axis I or Axis II disorders (ratings done by authors C.
A.B. and A.S.). None of the participants met criteria for alcohol
dependence within the past 2 years or substance abuse
within 6 months prior to testing. Exclusion criteria included
head injury, learning disability, hearing impairment, verbal IQ
less than 75, and alcohol or illicit substance use within 24 h
prior to testing. The number of individuals who smoked
cigarettes within 24 h of testing did not differ between
groups, and participants were not permitted to smoke during
the 40 min preceding testing, thus minimizing possible acute
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effects of nicotine on ERP amplitudes (Adler et al., 1993).
Findings reported below were unchanged when smoking
status was used as a statistical covariate.
All but one patient with schizophrenia was taking
antipsychotic medication (2 typical, 18 atypical), thus group
size was too small for statistical comparison between
medication subgroups. There were no significant correlations
between any electrophysiological variable and chlorproma-
zine equivalent dosage.
2.2. Stimuli and procedures
One-hundred and thirty paired stimuli were presented
binaurally while participants were seated in a sound
attenuated room. Stimuli were two different paired auditory
sounds: (1) standard click pairs (85% probability; N=110
trials, 3 ms duration, peak intensity 81 dB SPL as measured by
a Simpson Model 886 sound level meter, fast mode, “A”
weighting, SOA=500 ms) and (2) rare 1000 Hz paired tone
pips (15% probability, 3 ms duration, rise/fall of .75 ms, peak
intensity 81 dB SPL, SOA=500 ms). Inter-trial interval varied
randomly between 7 and 11 s (mean=9 s). Stimuli were
presented against a 58 dB SPL white-noise background. To
keep all participants alert, subjects were asked to respond by
button press to the rare paired tone pips.
2.3. EEG recordings and data processing
Electroencephalographic activity was collected from 29
recording sites (1000 Hz A/D rate; 0.10 Hz high pass, 200 Hz
low pass; gain=10 K; nose reference; impedances ≤10 kΩ)
using sintered Ag–AgCl electrodes.
2.3.1. ERP peak measurement
P50 responses at Cz were segmented (−50 to 400 ms),
baseline corrected, ocular artifacts were corrected (Grat-
ton et al., 1983), and remaining trials with values
exceeding ±100 μV were excluded from analyses. A 1–
50 Hz (24 dB/octave) bandpass filter was applied to
averaged data and peak amplitude was defined as the
difference in μV between the most positive point 40 to
80 ms after stimulus onset and the point of maximum
deflection on the preceding negative trough (Fig. 1).
Responses to the second click were measured within
±15 ms of the response to the first click. The amplitude
of the N100 response was defined as the most negative
point 80 to 150 ms after stimulus onset (referenced to
baseline).
2.3.2. Spectral frequency power
Frequency bands of interest were identified as low (1–
12 Hz), beta 1 (12–20 Hz), beta 2 (20–30 Hz) and gamma
(30–50 Hz). We did not further subdivide the low frequency
band because the ISI of 500 ms does not allow for reliable
measurement of low frequency activity. Raw EEG recordings
were segmented into 700 ms epochs (250 ms baseline), and
subjected to the same ocular correction and artifact rejection
criteria as the peak amplitude analyses. The time-varying
spectral power, Wx = jωðt; f Þ*sðtÞ j2 was computed for each
frequency (f) by convolving the average ERP signal, s(t), with
a complex-valued Morlet's wavelet, ω(t; f),
ωðt; f Þ = A⋅e2iπft⋅e−t
2
=2σ2t ð1Þ
where σf=1/(2πσt), and A = σ
−1
t ⋅ð2=πÞ1=2 is a Gabor
normalization factor (Tallon-Baudry and Bertrand, 1999). In
the context of Eq. (1), A yields the instantaneous amplitude
(Hermann et al., 2005, p. 240). The family of wavelets used
were characterized by the constant ratio f/σf=7. Signal
power was computed over the range of frequencies from 1 to
70 Hz in 1 Hz steps.
To identify the latency of the peak power within each
frequency band, the raw EEG was segmented from −100 to
500 ms and averaged across S1, S2, standard and rare trials for
each frequency band separately. The ‘frequency extraction’
procedure in Brain Vision Analyzer software (Brain Products,
Munich, Germany) converted the data into power within a
specified frequency range at each time point. We then
measured the latency at which the power peaked for each
subject, and used that average (±1.5 standard deviations) to
define the region that we analyzed our wavelet-based time–
frequency data. This approach allowed us to define the
window used in our time–frequency analysis based on the
points in which activity within that frequency band was
largest. For low frequency data the analysis window spanned
from 118–310 ms; for beta 1 activity it was 20–167 ms; for
Fig.1. ERPwaveforms (1–50 Hz filter) for each diagnostic group. The left panel shows thewaveforms in response to ‘standard’ stimuli and the right panel shows the
waveforms in response to ‘rare’ stimuli.
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beta 2 activity it was 23–157 ms; and for gamma it was 32–
74 ms.
2.4. Statistical analyses
A square root transformation was applied to the P50 peak
amplitude data to better approximate a normal distribution.
Statistical outliers were determined as participants with values
at least three times the interquartile range of the corresponding
participant group (Brenner et al., 2004), and were eliminated
from further analyses. Therewere nomore than six outliers in a
given analysis (three Sz and three controls). Difference scores
were computedacross click stimuli (S1–S2), rather than the S2/
S1 ratio, because it is a more psychometrically reliable index of
P50 evoked response attenuation (Smith et al., 1994). Within
and between-group contrasts were conducted using Repeated
measures ANOVA, with Diagnosis (SZ, HC) as the between-




Button-press responses to the presentation of the rare
stimuli did not differ between groups (control=98.6%
correct; SD=.03; schizophrenia=95.7% correct; SD=.06).
3.2. P50 ERPs
Repeated Measures ANOVA yielded: a main effect of
Salience, F(1,37)=32.8, p=.001, ηp2=.47, indicating larger
responses to rare compared to standard paired stimuli; amain
effect of Stimulus, F(1,37)=71.9, p=.001, ηp2=.66, indicating
larger responses to S1 than to S2; and a Salience × Stimulus
interaction, F(1,37)=11.2, p=.002, ηp2= .23, reflecting
greater S1 amplitude to rare compared to standard stimuli
for both groups (Table 1). For the S1–S2 amplitude difference
score, there was a main effect of Salience, F(1,39)=12.2,
p=.001, ηp2=.24, indicating a larger difference between S1
and S2 in response to rare compared to standard paired
stimuli for both groups1. Repeated measures ANOVAs were
repeated using only those ‘standard’ trials that immediately
preceded a rare trial, thereby ensuring the same number of
trials contributed to the average waveform for both trial
types. These analyses resulted in a main effect of Stimulus, F
(1,36)=26.1, p=.001, ηp2=.42, and a Salience × Stimulus
interaction, F(1,36)=15.8, p=.001, ηp2=.31, when using S1
and S2 amplitudes. Results using the S1–S2 difference score
did not change when this procedure was applied. There were
no group differences in P50 gating.
3.3. N100 ERPs
Repeated Measures ANOVA revealed: a main effect of
Salience, F(1,40)=118.7, p=.001, ηp2=.75, indicating larger
responses to rare compared to standard paired stimuli; amain
effect of Stimulus, F(1,40)=137.3, p=.001, ηp2=.77, indicat-
ing larger responses to S1 than S2; and a Stimulus × Diagnosis
interaction, F(1,40)=9.9, p=.003, ηp2=.20, reflecting greater
S1 amplitude by the healthy control group. Finally, therewas a
Salience × Stimulus interaction, F(1,40)=40.7, p=.001,
ηp2=.51, indicating greater S1 amplitude to rare compared
to standard stimuli for both groups. For the S1–S2 difference
scores, there was a main effect of Salience, F(1,40)=40.7,
p=.001, ηp2=.51, indicating a larger difference between S1
and S2 in response to rare compared to standard paired
stimuli for both groups.
3.4. Time frequency analyses
Repeated Measures ANOVA compared groups on power
values for each frequency band separately (see Table 1).
1 Analysis of the P50 responses and difference score in response to
frequent stimuli using different filter parameters (10–50 Hz) also did not
yield significant group differences.
Table 1
Untransformed ERP amplitudes (in uV) and power values (in uV2).
S1 M (SD) S2 M (SD) S1–S2 M (SD) S2/S1 (SD)
P50 ERP
Frequent
HN 4.62 (2.58) 1.55 (.89) 2.97 (2.47) .94 (2.45)
SZ 4.28 (2.46) 2.35 (2.11) 1.94 (3.14) .73 (.71)
Rare
HN 7.97 (4.23) 2.86 (2.46) 5.34 (4.63) .39 (.36)
SZ 8.01 (4.72) 2.92 (2.36) 5.09 (4.58) .50 (.45)
N100 ERP
Frequent
HN −14.51 (6.76) −3.25 (3.19) −11.25 (5.40) .200 (.16)
SZ −8.93 (3.91) −2.77 (1.90) −6.16 (3.78) .337 (.30)
Rare
HN −24.54 (10.66) −5.99 (3.81) −18.550 (9.57) .215 (.13)
SZ −16.14 (8.40) −5.11 (3.96) −11.028 (8.33) .281 (.34)
Low power (1–12 Hz)
Frequent
HN 4.78 (5.07) 1.56 (2.82) 3.22 (6.11)
SZ 3.69 (3.66) 1.98 (2.82) 1.71 (5.28)
Rare
HN 5.98 (5.39) .73 (1.12) 5.26 (5.68)
SZ 4.28 (1.90) 1.37 (1.83) 2.91 (2.70)
Beta 1 power (12–20 Hz)
Frequent
HN 2.94 (4.78) 1.92 (3.63) 1.01 (5.85)
SZ 3.13 (3.36) 1.55 (3.74) 1.58 (5.32)
Rare
HN 9.31 (7.76) 1.74 (2.76) 7.57 (8.60)
SZ 4.03 (4.54) 1.44 (1.79) 2.59 (4.49)
Beta 2 power (20–30 Hz)
Frequent
HN 2.34 (4.43) 1.90 (3.61) .439 (4.11)
SZ 2.65 (3.37) 2.02 (4.28) .628 (5.22)
Rare
HN 3.47 (4.05) 2.67 (2.76) .800 (3.81)
SZ 3.79 (4.52) 1.32 (2.00) 2.47 (3.91)
Gamma Power (30–50 Hz)
Frequent
HN 5.52 (7.79) 2.64 (6.21) 2.88 (7.57)
SZ 2.98 (5.78) 1.14 (2.18) 1.84 (5.67)
Rare
HN 7.38 (10.76) 2.12 (3.68) 5.26 (8.91)
SZ 6.28 (12.83) 2.30 (4.22) 3.98 (9.22)
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Within the low frequency (1–12 Hz) range, there was a main
effect of Stimulus, F(1,36)=41.94, p=.001, ηp2=.54, that
indicated greater power in response to S1 compared to S2
(Fig. 2). There were no significant findings using the
difference scores.
Within the beta 1 frequency range (12–20 Hz), analyses
revealed a main effect of Salience, F(1,36)=13.31, p=.001,
ηp2=.27, indicating greater beta power in response to rare
stimuli, and a main effect of Stimulus, F(1,36)=21.44,
p=.001, ηp2=.37, that indicated greater power in response
to S1 compared to S2. A Salience × Diagnosis interaction, F
(1,36)=5.92, p=.020, ηp2=.14, indicated less beta 1 power
in schizophrenia than in controls in response to rare stimuli. A
Salience × Stimulus interaction, F(1,36)=9.48, p=.004,
ηp2=.21, indicated greater beta 1 power in response to rare
S1 stimuli. Finally, there was a Salience × Stimulus ×
Diagnosis interaction, F(1,36)=11.41, p=.002, ηp2=.24. To
better understand this interaction, separate analyses were
performed in response to standard and rare stimuli. For
standard stimuli there was a main effect of Stimulus, F(1,36)=
4.93, p=.033, ηp2=.12, that indicated greater power in
response to S1. For rare stimuli there was a main effect of
Stimulus, F(1,36)=21.36, p=.001, ηp2=.37, and a signifi-
cant Stimulus × Diagnosis interaction, F(1,36)=5.48,
p=.025, ηp2=.13, that indicated lower beta 1 power in
response to S1 to rare stimuli by the schizophrenia group.
For the S1–S2 difference scores, there was a main effect of
Salience, F(1,40)=10.89, p=.002, ηp2=.21, and a Salience ×
Diagnosis interaction, F(1,40)=5.96, p=.019, ηp2=.13. These
findings indicated less change in beta 1 power from S1 to S2 in
response to rare stimuli pairs in schizophrenia (Fig. 2).
Within the beta 2 frequency range (20–30), analyses
revealed a main effect of Salience, F(1,34)=8.80, p=.005,
ηp2=.21, that indicated greater beta 2 power in response to
rare stimuli, and a main effect of Stimulus, F(1,34)=6.36,
p=.017, ηp2=.16, indicating greater power in response to S1
compared to S2 (Fig. 2). There were no significant findings
using the difference scores.
Gamma frequency power analyses revealed a marginally
significant main effect of Salience, F(1,38)=4.06, p=.051,
ηp2=.10, indicating greater gamma power in response to rare
compared to standard stimuli, and a main effect of Stimulus, F
(1,38)=12.79, p=.001, ηp2=.25, indicating greater gamma
power in response to S1 compared to S2 (Fig. 2). There were
no significant findings using the difference scores.
3.5. Time frequency and N100 amplitude correlations
Bivariate correlations were performed between beta 1
power and N100 amplitude for each group separately. Within
the control group N100 amplitude at S1 in response to rare
stimuli was significantly correlated with beta 1 power at S1 in
response to rare stimuli (r=.467, p=.044). Within the
schizophrenia group N100 amplitude at S1 in response to
frequent stimuli was significantly correlated with both beta
power at S1 in response to frequent (r=.536, p=.018) and
rare stimuli (r=.567, p=.011). In addition, within the
schizophrenia group N100 amplitude difference score to
frequent stimuli was negatively associated with beta 1 power
at S1 in response to rare stimuli (r=− .600, p=.008).
4. Discussion
Individuals with schizophrenia exhibited less neural
activity in the beta 1 frequency range (12–20 Hz) in response
to rare, more salient stimuli, an effect that was driven by the
low magnitude of their response to the initial stimulus in a
dual-click procedure. The N100 analyses revealed a similar
pattern of smaller S1 amplitudes in the schizophrenia group
resulting in schizophrenia patients having less N100 “gating”
Fig. 2.Wavelet-based time–frequency transforms of the averaged ERP waveform. The upper panels show power over time in response to standard stimuli, and the
lower panels show power over time in response to rare stimuli. Data from the healthy control group is shown on the left (S1 and S2 in columns) and the data from
the schizophrenia group is shown on the right (S1 and S2 in columns). Patients demonstrated reduced beta 1 power (12–20 Hz) in response to rare S1 stimuli.
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than the healthy controls, although this finding was not
specific to rare stimuli. Correlations between N100 amplitude
and beta 1 activity reflect a relationship between these two
measures; with N100 amplitudes to S1 (both frequent and
rare stimuli) positively correlated with beta 1 power to S1
(both frequent and rare stimuli). Interestingly, the salience-
driven deficits in schizophrenia were not seen in the low (1–
12 Hz), beta 2 (20–30 Hz) or gamma frequency (30–50 Hz)
range, and P50 amplitude gating did not differ between
groups. Taken together, the present findings suggest a
possible functional differentiation between sensory registra-
tion and mechanisms associated with sensory processing
during stages of stimulus evaluation and saliency detection
that may be dysfunctional in schizophrenia (Clementz et al.
2008).
In particular, our finding that schizophrenia patients
exhibited less S1 beta 1 power to rare stimuli may indicate
deficits in the stimulus evaluation stage of sensory encoding.
This deficit, along with sensory gating deficits in the later
stages of information processing (N100 and P200), is
consistent with a problem in the nervous system's ability to
detect and respond to salient or important information
(“gating in”) in schizophrenia (Boutros et al. 2004). In
addition, increased stimulus saliency as manipulated by ISI
(Kisley and Cromwell, 2006) and/or expectancy (Clementz et
al., 2002) has been associated with increased beta activity in
healthy controls, while less beta activity in response to S1 has
been associated with aberrant sensory gating scores in
healthy controls and patients with schizophrenia (Hong et
al., 2004; Hong et al., 2008). Finally, in-vitro hippocampal
stimulation studies suggest that beta oscillations may reflect
encoding and evaluation of a percept (Haenschel et al., 2000;
Hong et al., 2004; Traub et al., 1999). Taken together, these
findings suggest that oscillatory activity in the beta range
represents a measure of stimulus-driven salience detection
that is altered in schizophrenia. While it is impossible to
disentangle the effect of salience alone from the different
physical characteristics of the rare stimuli that make it salient,
this issue does not nullify the group differences that are the
main finding of this report.
P50 ERP amplitude was larger to rare compared to
standard paired stimuli, indicating sensitivity to salience.
However, the P50 gating score did not significantly differ
between groups. This finding, along with that of the gamma
band results, may indicate intact sensory registration in
patients with schizophrenia. There are, however, several
alternative interpretations of this result including: (1) the
range of P50 gating scores across studies is large and may be
related to a number of methodological factors (Blumenfeld
and Clementz, 2001; Bunney et al., 1999); (2) the effect size of
our P50 peak-picked results is small compared to those of our
N100 and frequency band results, suggesting lower discrimi-
native power in P50; (3) reductions in P50 and evoked
gamma responses may reflect pathophysiology that is present
in only select subgroups of patients with schizophrenia
(Johannesen et al., 2008); (4) the atypical medications
taken by the majority of the patients in this study may
further reduce the schizophrenia–normal effect size differ-
ences (Adler et al., 2004; Light et al., 2000); and (5) the use of
rare tone pairs in a button-press target detection procedure,
interspersed within the standard click pairs, may have altered
the fundamental nature of the dual-click procedure. Future
studies that clarify these issues, using larger sample sizes, are
warranted.
In summary, previous investigations have identified at
least two stages of auditory processing: stimulus registration
(i.e., encoding that a stimulus has been presented) and
evaluation (i.e., classifying the nature of the stimulus)
(Boutros and Belger, 1999). There is evidence to suggest that
neural oscillatory activity within the gamma and beta
frequency ranges, respectively, may support these functions.
The current study evaluated these functions in patients with
schizophrenia using a modified dual-click procedure. We
found that individuals with schizophrenia exhibited reduced
N100 amplitude in response to the initial click stimulus and
reduced beta 1 activity (12–20 Hz) in response to the initial
salient stimulus. Patients did not significantly differ from
healthy comparison subjects in P50 amplitude, low, beta 2 or
gamma activity. These findings extend previous research by
investigating the difference in neural response to both
standard and salient, or rare, paired stimuli within a more
detailed frequency band analysis than has previously been
reported in the literature (Blumenfeld and Clementz, 2001;
Johannesen et al., 2005). While P50 ERP amplitudes were
increased to rare stimuli in both groups, beta 1 activity (12–
20 Hz), which is associated with stimulus saliency and
evaluation, exhibited sensitivity to diagnosis. These findings
suggest that aberrant stimulus evaluation, especially as it
relates to stimulus salience detection, may be considered a
primary mechanism underlying sensory processing-related
EEG abnormalities in schizophrenia.
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